GASTROENTEROLOGY CLINICAL CASE CONFERENCE
February 18, 2015
4:30 pm – 5:30 pm
9 Penn Tower
BRIDGET GOODWIN, MD
Children’s Hospital of Philadelphia Fellow
and
MATTHEW WHITSON, MD
Hospital of the University of Pennsylvania Fellow
Target Audience
This program has been designed for departmental/institutional faculty, fellows, residents, medical students, and community physicians in the medical specialties of internal medicine, gastroenterology, pediatric gastroenterology, and pediatrics.
Educational Objectives
After completing this activity, participants should be able to:
· Review pathophysiology of a broad variety of complex gastrointestinal problems and disorders
· Describe the most recent treatment for a broad spectrum of GI diseases
· Improve effective communication skills
· Apply evidence from the current literature and incorporate new strategies, techniques and therapies in patient care
Accreditation
The Perelman School of Medicine at the University of Pennsylvania is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation of Credit
The Perelman School of Medicine at the University of Pennsylvania designates this live activity for a maximum of 1 AMA PRA Category 1 Credit ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Acknowledgement of Commercial Support*
NONE
For more information, please contact
Michele Fitzpatrick
215-898-0154
xx
Disclosure of Relevant Financial Relationships and Unapproved Uses of Products
It is policy at the Perelman School of Medicine at the University of Pennsylvania for individuals who are in a position to control the content of an educational activity to disclose to the learners all relevant financial relationships that they have with any commercial interest that provides products or services that may be relevant to the content of this continuing medical education activity. For this purpose we consider relationships of the person involved in the CME activity to include financial relationships of a spouse or partner.
The intent of this policy is not to prevent expert faculty with relevant relationship(s) with commercial interest(s) from involvement in CME, but rather to ensure that Penn CME-certified activities promote quality and safety, are effective in improving medical practice, are based on valid content, and are independent of control from commercial interests and free of commercial bias. Peer review of all content was conducted for all faculty presentations whose disclosure information provided to the Penn Office of CME was found to contain relationships that created a conflict of interest relative to the topic of their presentation. In addition, all faculty were instructed to provide balanced, scientifically rigorous and evidence-based presentations.
The staff in the Office of CME at the Perelman School of Medicine at the University of Pennsylvania, Mila Kostic, Director of CME and the peer reviewer Zalman Agus, MD, Associate Dean for CME, have disclosed that they have no relevant financial relationships with any commercial interests related to the content of this educational activity.
The following individuals have disclosed that they have no relevant financial relationships with any commercial interests related to the content of this educational activity:
Planning Committee Member & Presenter Name
Anil Rustgi, MD
Presenter Name
Gregory Ginsberg, MD / David Leiman, MD / Josephine Ni, MD / Brian Riff, MD / Noah Hoffman, MDMaire Conrad, MD / Kirk Wangensteen, MD / Karl Bezak, MD / Ronen Stein, MD / Giorgio Roccaro, MD
Xiao Zhao, MD / Tatyana Kushner, MD / Lauren Nephew, MD / Betsy Maxwell, MD / Amanke Oranu, MD
Koushik Das, MD / Matthew Whitson, MD / Nina Sainath, MD / Therese Bitterman, MD / Lisa Fahey, MD
Alyssa Kriegermeier, MD / Claudio Rivera, MD / Gene Ma, MD / Bridget Goodwin, MD
The following individuals have reported the listed relevant financial relationships with commercial interests related to the content of this educational activity.
Planning Committee & Presenter Name Name of Commercial Interest Relationship
Gary R. Lichtenstein, MD Abbott Corp/ Abbvie, Elan, Hospira, Millenium Pharma Consultant
Ono Pharma, Pfizer Pharma, Santarus, Schering-Plough Corp, Takeda Consultant
Alaven, Janssen Orthobiotech, Ferring, Prometheus Lab Inc Consultant, Research
Salix Pharma, Shire Pharma, UCB, Warner Chilcotte Consultant, Research
Bristol Myers Squibb Research
Ironwood Honorarium
David C. Metz, MD Takeda, Salix, Asstra Zeneca Consultant
AAA, Lexicon, Astari Grant PI
Presenter Name Name of Commercial Interest Relationship
K. Rajender Reddy, MD Gilead, Merck, Genentech-Roche, Vertex Honorarium
Janssen, Abbvie, BMS Honorarium
Gilead, Abbvie, BMS, Merck, Janssen Institution Research Support
Relevant Financial Relationships: Financial relationships are those relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received or expected
Disclosure of Unapproved Uses of Products
Presenter name Product Investigational and/or Off-label Use